Intelligence · Clinical Pipeline
Autoimmune & immunology · Phase II
Autoimmune & immunology programs at Phase II — ClinicalTrials.gov pipeline intelligence.
- Programs
- 327
Quick answer
Autoimmune & immunology Phase II programs: NovaPharmaNews indexes 327 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 26 programs
- Teva Pharma 13 programs
- Lakefront Biotherapeutics NV 12 programs
- Anaxis Pharma 11 programs
- Chinese Academy of 11 programs
- Novartis India 11 programs
- Sanofi-Aventis U.S 10 programs
- Pacira Ireland 9 programs
- United Therapeutics Europe 8 programs
- RIGEL PHARMACEUTICALS 6 programs
- Regeneron UK 6 programs
- Vertex Pharmaceuticals (Australia) 6 programs
-
FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TOCILIZUMAB, YTB323
Novartis Pharmaceuticals
Systemic Lupus Erythematosus., Lupus Nephritis
1 trial -
FLUDARABINE PHOSPHATE, YTB323, CYCLOPHOSPHAMIDE, TOCILIZUMAB
Novartis Pharmaceuticals
Difficult to treat rheumatoid arthritis, Severe, refractory Sjogren’s disease with organ involvement
1 trial -
FT819
Zafatek
Lupus Nephritis
1 trial -
FX005
Pacira Ireland Limited
Osteoarthritis, Knee
1 trial -
FX006
Pacira Ireland Limited
Osteoarthritis of the Shoulder
1 trial -
FX006 10 mg
Pacira Ireland Limited
Osteoarthritis of the Knee
2 trials -
FX006 32 mg
Pacira Ireland Limited
Bilateral Knee Osteoarthritis
1 trial -
FX006 32 mg
Pacira Ireland Limited
Osteoarthritis of the Shoulder
1 trial -
FX006 32 mg
Pacira Ireland Limited
Post-traumatic Osteoarthritis of the Knee
1 trial -
FX006 32 mg
Pacira Ireland Limited
Osteoarthritis, Hip
1 trial -
Filgotinib
Lakefront Biotherapeutics NV
Fistulizing Crohn's Disease
1 trial -
Filgotinib
Lakefront Biotherapeutics NV
Small Bowel Crohn's Disease
1 trial -
Fostamatinib
AstraZeneca
Rheumatoid Arthritis
1 trial -
Fostamatinib 150 mg bid
RIGEL PHARMACEUTICALS INC
Warm Antibody Autoimmune Hemolytic Anemia
1 trial -
Fostamatinib Disodium (R935788)
RIGEL PHARMACEUTICALS INC
Systemic Lupus Erythematosus
1 trial -
Fostamatinib disodium (R935788)
RIGEL PHARMACEUTICALS INC
Rheumatoid Arthritis
2 trials -
Frexalimab, Matched Placebo for Test
Sanofi-aventis Healthcare Pty Ltd
Systemic lupus erythematosus
1 trial -
GLPG0259 oral capsule
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
1 trial -
GLPG0634
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
4 trials -
GLPG0634
Lakefront Biotherapeutics NV
Crohn's Disease
1 trial -
GLPG0974
Lakefront Biotherapeutics NV
Ulcerative Colitis
1 trial -
GLPG1205
Lakefront Biotherapeutics NV
Ulcerative Colitis
1 trial -
GLPG1972
Lakefront Biotherapeutics NV
Osteoarthritis
1 trial -
GLPG3667
Lakefront Biotherapeutics NV
Systemic Lupus Erythematosus
1 trial -
GLPG3970
Lakefront Biotherapeutics NV
Rheumatoid Arthritis
1 trial -
GLPG3970
Lakefront Biotherapeutics NV
Ulcerative Colitis
1 trial -
GR-MD-02
GALECTIN THERAPEUTICS INC
Psoriasis
1 trial -
GSK3196165 Dose 1
GlaxoSmithKline
Arthritis, Rheumatoid
1 trial -
Gazyvaro 1,000 mg concentrate for solution for infusion., CellCept 1 g/5 ml powder for oral suspension, Gazyvaro Placebo, Myfenax 500 mg film-coated tablets
Hoffmann-La Roche
Lupus Nephritis (LN)
1 trial -
Glutamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rheumatic Heart Disease
1 trial -
Golimumab, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Placebo for Guselkumab, Golimumab and JNJ-78934804, JNJ-78934804
Janssen-Cilag International N.V.
Moderately to Severely Active Crohn's Disease
1 trial -
Guselkumab
Janssen Cilag International NV
Colitis, Ulcerative
1 trial -
Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL, Placebo to Guselkumab and Golimumab and JNJ-78934804, Golimumab, JNJ-78934804
Janssen-Cilag International N.V.
Moderately to Severely Active Ulcerative Colitis
1 trial -
Human Umbilical Cord derived MSCs
CytoMed Therapeutics Ltd
Lupus Nephritis
1 trial -
Humira 40 mg solution for injection in pre-filled syringe, Lutikizumab, Humira 80 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe, Lutikizumab, Humira 40 mg solution for injection in pre-filled syringe, Humira 40 mg solution for injection in pre-filled syringe
AbbVie Deutschland GmbH & Co. KG
Ulcerative Colitis
1 trial -
Huzhang granule
Universal Integrated
Gouty Arthritis
1 trial -
ICP-022
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Systemic Lupus Erythematosus
1 trial -
IDOR-1117-2520 matching placebo
Lacuna Pharma Pty Ltd
Moderate to severe chronic plaque psoriasis
1 trial -
IRX4204
IO Biotech
Psoriasis
1 trial -
ISIS 104838
IONIS PHARMACEUTICALS INC
Rheumatoid Arthritis
1 trial -
ISIS CRP Rx or Placebo
IONIS PHARMACEUTICALS INC
Rheumatoid Arthritis
1 trial -
Ibuprofen-PC
Protalix BioTherapeutics
Osteoarthritis
1 trial -
Imsidolimab
Vanda Pharmaceuticals Netherlands B.V.
Generalized Pustular Psoriasis
1 trial -
Indigo naturalis ointment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis
1 trial -
JBT-101
Corbus Pharmaceuticals Holdings
Systemic Lupus Erythematosus
1 trial -
JNJ-77242113
Janssen Cilag International NV
Colitis, Ulcerative
1 trial -
JNJ-81241459, JNJ-81241459 200mg, placebo tablet, JNJ-81241459, JNJ-81241459 50mg, placebo tablet
Janssen-Cilag International N.V.
Plaque Psoriasis
1 trial -
JNJ-88545223, JNJ-88545223, JNJ-88545223 Placebo
Janssen-Cilag International N.V.
Active Psoriatic Arthritis
1 trial
Frequently asked questions
How many autoimmune & immunology Phase II programs exist?
327 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs